Targeted Oncology,volume 5,issue 4  (12-2013)

Period of time： 2013年4期

Publisher： Springer Publishing Company

Founded in： 2006

Total resources： 10

ISSN： 1776-2596

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Targeted Oncology,volume 5,issue 4

Menu

Personalized medicine in lung adenocarcinoma: no longer a hope or a passing fashion, but a new reality

By Morère Jean-François in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 229-230 (2)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

By Rossi David in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 231-235 (5)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice

By Wang Yixiang in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 237-243 (7)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992

By Spicer James in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 245-255 (11)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Examining the safety profile of angiogenesis inhibitors: implications for clinical practice

By Reck Martin in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 257-267 (11)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Targeting mTOR in cancer: renal cell is just a beginning

By Azim Hamdy in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 269-280 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy

By Driscoll James in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 281-289 (9)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Use of rituximab in three children with relapsed/refractory Burkitt lymphoma

By Akbayram Sinan in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 291-294 (4)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Tufted hair folliculitis in a woman treated with trastuzumab

By Rosman Ilana in (2010)

Targeted Oncology,volume 5,issue 4 , Vol. 5, Iss. 4, 2010-12 , pp. 295-296 (2)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Total 9 item(s)